Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription

Oncogene volume 26, pages 7231–7239 (2007)Cite this article

Abstract

The AML1 transcription factor complex is the most frequent target of leukemia-associated chromosomal translocations. Homeodomain-interacting protein kinase 2 (HIPK2) is a part of the AML1 complex and activates AML1-mediated transcription. However, chromosomal translocations and mutations of HIPK2 have not been reported. In the current study, we screened mutations of the HIPK2 gene in 50 cases of acute myeloid leukemia (AML) and in 80 cases of myelodysplastic syndrome (MDS). Results indicated there were two missense mutations (R868W and N958I) in the speckle-retention signal (SRS) domain of HIPK2. Subcellular localization analyses indicated that the two mutants were largely localized to nuclear regions with conical or ring shapes, and were somewhat diffused in the nucleus, in contrast to the wild type, which were mainly localized in nuclear speckles. The mutations impaired the overlapping localization of AML1 and HIPK2. The mutants showed decreased activities and a dominant-negative function over wild-type protein in AML1- and p53-dependent transcription. These findings suggest that dysfunction of HIPK2 may play a role in the pathogenesis of leukemia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML et al. (2006). Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 25: 3955–3965.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RS et al. (1996). The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 14: 33–41.

    Article  CAS  PubMed  Google Scholar 

  • Carapeti M, Aguiar RC, Goldman JM, Cross NC . (1998). A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood 91: 3127–3133.

    CAS  PubMed  Google Scholar 

  • Carapeti M, Aguiar RC, Watmore AE, Goldman JM, Cross NC . (1999). Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13). Cancer Genet Cytogenet 113: 70–72.

    Article  CAS  PubMed  Google Scholar 

  • Chaffanet M, Gressin L, Preudhomme C, Soenen-Cornu V, Birnbaum D, Pebusque MJ . (2000). MOZ is fused to p300 in an acute monocytic leukemia with t(8;22). Genes Chromosomes Cancer 28: 138–144.

    Article  CAS  PubMed  Google Scholar 

  • Choi CY, Kim YH, Kwon HJ, Kim Y . (1999). The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J Biol Chem 274: 33194–33197.

    Article  CAS  PubMed  Google Scholar 

  • D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4: 11–19.

    Article  CAS  PubMed  Google Scholar 

  • de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A . (1991). The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675–684.

    Article  CAS  PubMed  Google Scholar 

  • de The H, Vivanco-Ruiz MM, Tiollais P, Stunnenberg H, Dejean A . (1990). Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343: 177–180.

    Article  CAS  PubMed  Google Scholar 

  • Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN et al. (1999). SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation. J Cell Sci 112 (Part 3): 381–393.

    CAS  PubMed  Google Scholar 

  • Engelhardt OG, Boutell C, Orr A, Ullrich E, Haller O, Everett RD . (2003). The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp Cell Res 283: 36–50.

    Article  CAS  PubMed  Google Scholar 

  • Gamou T, Kitamura E, Hosoda F, Shimizu K, Shinohara K, Hayashi Y et al. (1998). The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood 91: 4028–4037.

    CAS  PubMed  Google Scholar 

  • Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P et al. (1995). Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 92: 4917–4921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T . (2004). High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood 103: 2316–2324.

    Article  CAS  PubMed  Google Scholar 

  • Hofmann TG, Jaffray E, Stollberg N, Hay RT, Will H . (2005). Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification. J Biol Chem 280: 29224–29232.

    Article  CAS  PubMed  Google Scholar 

  • Hofmann TG, Mincheva A, Lichter P, Droge W, Schmitz ML . (2000). Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34. Biochimie 82: 1123–1127.

    Article  CAS  PubMed  Google Scholar 

  • Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. (2002). Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 4: 1–10.

    Article  CAS  PubMed  Google Scholar 

  • Hofmann TG, Stollberg N, Schmitz ML, Will H . (2003). HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res 63: 8271–8277.

    CAS  PubMed  Google Scholar 

  • Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M et al. (1997). Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90: 4699–4704.

    CAS  PubMed  Google Scholar 

  • Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Takeuchi K, Maki K et al. (2000). Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis. Blood 96: 3154–3160.

    CAS  PubMed  Google Scholar 

  • Kakizuka A, Miller Jr WH, Umesono K, Warrell Jr RP, Frankel SR, Murty VV et al. (1991). Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663–674.

    Article  CAS  PubMed  Google Scholar 

  • Kamitani T, Kito K, Nguyen HP, Wada H, Fukuda-Kamitani T, Yeh ET . (1998). Identification of three major sentrinization sites in PML. J Biol Chem 273: 26675–26682.

    Article  CAS  PubMed  Google Scholar 

  • Kastner P, Perez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B et al. (1992). Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J 11: 629–642.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim YH, Choi CY, Kim Y . (1999). Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1. Proc Natl Acad Sci USA 96: 12350–12355.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kim YH, Choi CY, Lee SJ, Conti MA, Kim Y . (1998). Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 273: 25875–25879.

    Article  CAS  PubMed  Google Scholar 

  • Kim YH, Sung KS, Lee SJ, Kim YO, Choi CY, Kim Y . (2005). Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1. FEBS Lett 579: 6272–6278.

    Article  CAS  PubMed  Google Scholar 

  • Kitabayashi I, Aikawa Y, Nguyen LA, Yokoyama A, Ohki M . (2001a). Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J 20: 7184–7196.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kitabayashi I, Aikawa Y, Yokoyama A, Hosoda F, Nagai M, Kakazu N et al. (2001b). Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation. Leukemia 15: 89–94.

    Article  CAS  PubMed  Google Scholar 

  • Kitabayashi I, Yokoyama A, Shimizu K, Ohki M . (1998). Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 17: 2994–3004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Krug U, Ganser A, Koeffler HP . (2002). Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene 21: 3475–3495.

    Article  CAS  PubMed  Google Scholar 

  • Lin X, Sun B, Liang M, Liang YY, Gast A, Hildebrand J et al. (2003). Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 11: 1389–1396.

    Article  CAS  PubMed  Google Scholar 

  • Mahajan R, Delphin C, Guan T, Gerace L, Melchior F . (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97–107.

    Article  CAS  PubMed  Google Scholar 

  • Matunis MJ, Coutavas E, Blobel G . (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135: 1457–1470.

    Article  CAS  PubMed  Google Scholar 

  • Matunis MJ, Wu J, Blobel G . (1998). SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1, to the nuclear pore complex. J Cell Biol 140: 499–509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meyers S, Downing JR, Hiebert SW . (1993). Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 13: 6336–6345.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H et al. (1994). Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13: 504–510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitelman F, Mertens F, Johansson B . (1997). A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417–474.

    Article  CAS  PubMed  Google Scholar 

  • Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M . (1991). t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88: 10431–10434.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moller A, Sirma H, Hofmann TG, Rueffer S, Klimczak E, Droge W et al. (2003a). PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. Cancer Res 63: 4310–4314.

    PubMed  Google Scholar 

  • Moller A, Sirma H, Hofmann TG, Staege H, Gresko E, Ludi KS et al. (2003b). Sp100 is important for the stimulatory effect of homeodomain-interacting protein kinase-2 on p53-dependent gene expression. Oncogene 22: 8731–8737.

    Article  PubMed  Google Scholar 

  • Nguyen LA, Pandolfi PP, Aikawa Y, Tagata Y, Ohki M, Kitabayashi I . (2005). Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 105: 292–300.

    Article  CAS  PubMed  Google Scholar 

  • Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JD . (1993). The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc Natl Acad Sci USA 90: 7784–7788.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M et al. (1993). PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90: 6859–6863.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Okada H, Watanabe T, Niki M, Takano H, Chiba N, Yanai N et al. (1998). AML1(−/−) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene. Oncogene 17: 2287–2293.

    Article  CAS  PubMed  Google Scholar 

  • Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR . (1996). AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321–330.

    Article  CAS  PubMed  Google Scholar 

  • Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T et al. (1999). Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93: 1817–1824.

    CAS  PubMed  Google Scholar 

  • Pierantoni GM, Fedele M, Pentimalli F, Benvenuto G, Pero R, Viglietto G et al. (2001). High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 20: 6132–6141.

    Article  CAS  PubMed  Google Scholar 

  • Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL et al. (2000). High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood 96: 2862–2869.

    CAS  PubMed  Google Scholar 

  • Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R et al. (1995). The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85: 3662–3670.

    CAS  PubMed  Google Scholar 

  • Rui Y, Xu Z, Lin S, Li Q, Rui H, Luo W et al. (2004). Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation. EMBO J 23: 4583–4594.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K et al. (1996). Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc Natl Acad Sci USA 93: 12359–12363.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Satake N, Ishida Y, Otoh Y, Hinohara S, Kobayashi H, Sakashita A et al. (1997). Novel MLL-CBP fusion transcript in therapy-related chronic myelomonocytic leukemia with a t(11;16)(q23;p13) chromosome translocation. Genes Chromosomes Cancer 20: 60–63.

    Article  CAS  PubMed  Google Scholar 

  • Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B et al. (1997). MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 94: 8732–8737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sung KS, Go YY, Ahn JH, Kim YH, Kim Y, Choi CY . (2005). Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation. FEBS Lett 579: 3001–3008.

    Article  CAS  PubMed  Google Scholar 

  • Taki T, Sako M, Tsuchida M, Hayashi Y . (1997). The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene. Blood 89: 3945–3950.

    CAS  PubMed  Google Scholar 

  • Tomasini R, Samir AA, Carrier A, Isnardon D, Cecchinelli B, Soddu S et al. (2003). TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J Biol Chem 278: 37722–37729.

    Article  CAS  PubMed  Google Scholar 

  • Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA . (1996a). Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93: 3444–3449.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X et al. (1996b). The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 87: 697–708.

    Article  CAS  PubMed  Google Scholar 

  • Wang Y, Hofmann TG, Runkel L, Haaf T, Schaller H, Debatin K et al. (2001). Isolation and characterization of cDNAs for the protein kinase HIPK2. Biochim Biophys Acta 1518: 168–172.

    Article  CAS  PubMed  Google Scholar 

  • Wiggins AK, Wei G, Doxakis E, Wong C, Tang AA, Zang K et al. (2004). Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J Cell Biol 167: 257–267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Q, Nottke A, Goodman RH . (2005). Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis. Proc Natl Acad Sci USA 102: 2802–2807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH . (2003). Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115: 177–186.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Oncology Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan

    X-L Li, Y Arai, Y Shima, H Yoshida, S Rokudai, Y Aikawa & I Kitabayashi

  2. Research Institute for Radiation Biology and Medicine, Hiroshima University, Minami-ku, Hiroshima, Japan

    H Harada & A Kimura

Authors
  1. X-L Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Harada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Shima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H Yoshida
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Rokudai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y Aikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I Kitabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I Kitabayashi.

Additional information

Supplementary Information accompanies the paper on the Oncogene Web site (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, XL., Arai, Y., Harada, H. et al. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription. Oncogene 26, 7231–7239 (2007). https://doi.org/10.1038/sj.onc.1210523

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210523

Keywords

This article is cited by

Search

Advanced search

Quick links